ALXO
USDALX Oncology Holdings Inc. Common Stock
$1.460-0.060 (-3.947%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.520
High
$1.600
Low
$1.460
Volume
0.54M
Company Fundamentals
Market Cap
78.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.93M
Exchange
NMS
Currency
USD
52-Week Range
Low $0.404Current $1.460High $2.27
Related News
GlobeNewswire
ALX Oncology to Report Third Quarter 2025 Financial Results and Pipeline Progress Including Evorpacept CD47 Biomarker Data to be Presented at Upcoming SITC Annual Meeting
SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (NASDAQ:ALXO), a clinical-stage biotechnology company advancing a pipeline of
View more
GlobeNewswire
ALX Oncology Announces Preclinical Data and Phase 1 Trial-in-Progress Presentations of ALX2004, a Novel EGFR-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
-Two poster presentations showcase best- and first-in-class potential of ALX2004, a novel, antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors -Robust body of preclinical data supports
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.